Terumo (OTCMKTS:TRUMY) Posts Earnings Results

Terumo (OTCMKTS:TRUMY) announced its earnings results on Friday. The company reported $0.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.11, Zacks reports. Terumo had a return on equity of 9.01% and a net margin of 11.74%.

Terumo Stock Performance

Terumo stock traded up $0.50 during trading on Friday, reaching $12.68. The company had a trading volume of 295,120 shares, compared to its average volume of 379,323. The firm has a market capitalization of $18.70 billion, a price-to-earnings ratio of 21.86 and a beta of 0.62. The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07. The firm’s 50-day simple moving average is $13.08 and its 200 day simple moving average is $14.01. Terumo has a 52 week low of $12.08 and a 52 week high of $19.64.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on TRUMY. Zacks Research upgraded Terumo to a “hold” rating in a report on Thursday, April 9th. Nomura upgraded shares of Terumo to a “hold” rating in a research note on Tuesday, February 24th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.